insulin (NNC0268-0965) / Novo Nordisk - LARVOL DELTA

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine (clinicaltrials.gov) - P1; N=86; Completed; Sponsor: Novo Nordisk A/S; Active, not recruiting ➔ Completed

Clinical • Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus • MRI

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine (clinicaltrials.gov) - P1; N=86; Active, not recruiting; Sponsor: Novo Nordisk A/S; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus • MRI

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine (clinicaltrials.gov) - P1; N=86; Recruiting; Sponsor: Novo Nordisk A/S; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus • MRI

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine (clinicaltrials.gov) - P1; N=86; Not yet recruiting; Sponsor: Novo Nordisk A/S

Clinical • New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus

A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes (clinicaltrials.gov) - P1; N=36; Completed; Sponsor: Novo Nordisk A/S; Recruiting ➔ Completed

Clinical • Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus

A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes (clinicaltrials.gov) - P1; N=36; Recruiting; Sponsor: Novo Nordisk A/S; Trial completion date: Mar 2020 ➔ Aug 2020; Trial primary completion date: Mar 2020 ➔ Aug 2020

Clinical • Trial completion date • Trial primary completion date

A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes (clinicaltrials.gov) - P1; N=78; Completed; Sponsor: Novo Nordisk A/S; Active, not recruiting ➔ Completed

Clinical • Trial completion

A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes (clinicaltrials.gov) - P1; N=66; Active, not recruiting; Sponsor: Novo Nordisk A/S; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed

A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes (clinicaltrials.gov) - P1; N=36; Recruiting; Sponsor: Novo Nordisk A/S; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open

A Study to Look at How Safe NNC0268-0965 is in People With Type 2 Diabetes (clinicaltrials.gov) - P1; N=36; Not yet recruiting; Sponsor: Novo Nordisk A/S

Clinical • New P1 trial